These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11078501)

  • 41. [METHODOLOGIC PROBLEMS OF SENTINEL LYMPH NODE BIOPSY IN PATIENTS WITH BREAST CANCER].
    Krivorotko PV; Kanaev SV; Semiglazov VF; Novikov SN; Krzhivitsky PI; Semenov II; Turkevich EA; Busko EA; Donskikh RV; Bryantseva ZhV; Piskunov EA; Trufanova ES; Chernaya AV
    Vopr Onkol; 2015; 61(3):418-23. PubMed ID: 26242155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
    Mamtani A; Morrow M
    Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
    [No Abstract]   [Full Text] [Related]  

  • 43. Sentinel-node biopsy in breast cancer.
    De Salvo GL; Del Bianco P; Zavagno G
    N Engl J Med; 2003 Nov; 349(20):1968-71; author reply 1968-71. PubMed ID: 14626250
    [No Abstract]   [Full Text] [Related]  

  • 44. A plea for the pathologically accurate sentinel node.
    Copeland EM
    Ann Surg Oncol; 1999 Sep; 6(6):522-3. PubMed ID: 10493617
    [No Abstract]   [Full Text] [Related]  

  • 45. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
    Salmon RJ; Bouillet TH; Lewis JS; Clough KB
    Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
    [No Abstract]   [Full Text] [Related]  

  • 46. [Sentinel node biopsy in breast cancer patients: recommendations for introduction of this technique].
    Meijer S
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2878-9. PubMed ID: 10065264
    [No Abstract]   [Full Text] [Related]  

  • 47. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN.
    van la Parra RF; Peer PG; Ernst MF; Bosscha K
    Eur J Surg Oncol; 2011 Apr; 37(4):290-9. PubMed ID: 21316185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sentinel Lymph Node Dissection in Locally Recurrent Breast Cancer.
    Uth CC; Christensen MH; Oldenbourg MH; Kjær C; Garne JP; Teilum D; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2015 Aug; 22(8):2526-31. PubMed ID: 25564177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Squamous inclusion cyst in a sentinel axillary lymph node associated with breast malignancy.
    Haroon S; Faridi N; Fatima S
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):50-2. PubMed ID: 22237193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions.
    Cody HS
    J Surg Oncol; 2007 May; 95(6):440-2. PubMed ID: 17458860
    [No Abstract]   [Full Text] [Related]  

  • 51. Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.
    Canavese G; Dozin B; Vecchio C; Tomei D; Villa G; Carli F; Del Mastro L; Levaggi A; Rossello C; Spinaci S; Bruzzi P; Catturich A
    Eur J Surg Oncol; 2011 Aug; 37(8):688-94. PubMed ID: 21696914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance and management of extra-axillary sentinel lymph nodes: worthwhile or irrelevant?
    Cody HS
    Surg Oncol Clin N Am; 2010 Jul; 19(3):507-17. PubMed ID: 20620924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.
    Khan SA
    J Clin Oncol; 2009 Nov; 27(33):5494-6. PubMed ID: 19826108
    [No Abstract]   [Full Text] [Related]  

  • 54. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; De Luca R; Irlandese E; Gili S; Lo Schiavo F
    Minerva Chir; 2007 Apr; 62(2):93-9. PubMed ID: 17353851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema.
    Casabona F; Bogliolo S; Ferrero S; Boccardo F; Campisi C
    Ann Surg Oncol; 2008 Nov; 15(11):3318-9. PubMed ID: 18709416
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of sentinel node biopsy expands.
    Peres J
    J Natl Cancer Inst; 2013 Oct; 105(19):1423-4. PubMed ID: 24052620
    [No Abstract]   [Full Text] [Related]  

  • 58. Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.
    Chakravorty A; Sanmugalingam N; Shrestha A; Thomee E; Rusby J; Roche N; MacNeill F
    Eur J Surg Oncol; 2011 Feb; 37(2):122-6. PubMed ID: 21095094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical importance of micrometastasis in sentinel lymph nodes.
    Ozcinar B; Muslumanoglu M; Igci A; Gurdal SO; Yavuz E; Kecer M; Dagoglu T; Ozmen V
    Breast; 2011 Feb; 20(1):31-3. PubMed ID: 20846864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.